AKT1 and neoplasm: Decreased miR-424-5p levels subsequently elevate the expression of SRY-box transcription factor 9 (SOX9) and activate the PI3K/AKT pathway, culminating in accelerated tumor progression in cholangiocarcinoma (Ni et al., 2023).